Qi Wei
20Patents
2h-index
22Co-inventors
53Inventor score
Filing activity: Jun 6, 2008 → Jul 17, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10519188B2 | Cyclic di-nucleotide compounds and methods of use | Chemistry; Metallurgy | 5 | Active |
| US11873291B2 | Quinoline cGAS antagonist compounds | Chemistry; Metallurgy | 3 | Active |
| US7960420B2 | Diazonamide analogs with improved solubility | Human Necessities | 2 | Active |
| US11033635B2 | Antibody-STING agonist conjugates and their use in immunotherapy | Human Necessities | 2 | Active |
| US7989482B2 | Indoline anti-cancer agents | Chemistry; Metallurgy | 1 | Active |
| US8153619B2 | Diazonamide analogs | Human Necessities | 1 | Active |
| US7851620B2 | Methods for preparing diazonamides | Chemistry; Metallurgy | 1 | Active |
| US12134609B2 | Quinoline cGAS antagonist compounds | Chemistry; Metallurgy | 0 | Active |
| US12281078B2 | Quinoline cGAS antagonist compounds | Chemistry; Metallurgy | 0 | Active |
| US8334311B2 | Indoline anti-cancer agents | Chemistry; Metallurgy | 0 | Active |
| US8846734B2 | Diazonamide analogs | Chemistry; Metallurgy | 0 | Active |
| US8592469B2 | Diazonamide analogs | Chemistry; Metallurgy | 0 | Active |
| US8476256B2 | Diazonamide analogs | Human Necessities | 0 | Active |
| US11213592B2 | Antibody-sting agonist conjugates and their use in immunotherapy | Human Necessities | 0 | Active |
| US11299512B2 | Cyclic di-nucleotide compounds and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12311030B2 | Antibody-sting agonist conjugates and their use in immunotherapy | Human Necessities | 0 | Active |
| US7982051B2 | Methods for preparing diazonamides | Chemistry; Metallurgy | 0 | Active |
| US10829427B2 | Naphthoquinones, pro-drugs, and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US8299268B2 | Methods for preparing diazonamides | Chemistry; Metallurgy | 0 | Active |
| US12091387B2 | Quinoline cGAS antagonist compounds | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.